Tempest Therapeutics Inc (NASDAQ: TPST) started the day on Wednesday, with a price decrease of -4.56% at $0.85, before settling in for the price of $0.89 at the close. Taking a more long-term approach, TPST posted a 52-week range of $0.80-$6.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 62.66%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 29.53%. This publicly-traded company’s shares outstanding now amounts to $43.64 million, simultaneously with a float of $39.62 million. The organization now has a market capitalization sitting at $36.90 million. At the time of writing, stock’s 50-day Moving Average stood at $1.0351, while the 200-day Moving Average is $2.2115.
Tempest Therapeutics Inc (TPST) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Tempest Therapeutics Inc’s current insider ownership accounts for 9.21%, in contrast to 5.50% institutional ownership. Preceding that transaction, on Aug 08 ’24, Company’s 10% Owner sold 400,000 for 1.35, making the whole transaction’s value amount to 540,040. This particular insider is now the holder of 597,940 in total.
Tempest Therapeutics Inc (TPST) Earnings and Revenue Records
Tempest Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 29.53% and is forecasted to reach -1.04 in the upcoming year.
Tempest Therapeutics Inc (NASDAQ: TPST) Trading Performance Indicators
Let’s observe the current performance indicators for Tempest Therapeutics Inc (TPST). It’s Quick Ratio in the last reported quarter now stands at 1.69. The Stock has managed to achieve an average true range (ATR) of 0.08.
In the same vein, TPST’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.54, a figure that is expected to reach -0.25 in the next quarter, and analysts are predicting that it will be -1.04 at the market close of one year from today.
Technical Analysis of Tempest Therapeutics Inc (TPST)
If we take a close look at the recent performances of Tempest Therapeutics Inc (NASDAQ: TPST), its last 5-days Average volume was 1.24 million that shows plunge from its year to date volume of 2.06 million. During the previous 9 days, stock’s Stochastic %D was recorded 22.18% While, its Average True Range was 0.0737.
Raw Stochastic average of Tempest Therapeutics Inc (TPST) in the period of the previous 100 days is set at 3.30%, which indicates a major fall in contrast to 7.45% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 48.66% that was lower than 101.30% volatility it exhibited in the past 100-days period.
